Pfizer
Patents, Design & Utilities

Last updated:

List of all Pfizer patents 451 in total

Status Patent
Grant
Utility: Aminopyrimidinyl compounds External link
Filling date: 13 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Compositions and methods relating to a mutant Clostridium difficile toxin External link
Filling date: 13 Sep 2025 Issue date: 20 Apr 2021
Application
Utility: COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS External link
Filling date: 13 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS External link
Filling date: 13 Sep 2025 Issue date: 15 Apr 2021
Grant
Utility: N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors External link
Filling date: 13 Sep 2025 Issue date: 13 Apr 2021
Application
Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF External link
Filling date: 13 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY AVELUMAB External link
Filling date: 13 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITOR External link
Filling date: 13 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITOR External link
Filling date: 13 Sep 2025 Issue date: 8 Apr 2021
Grant
Utility: Cyclopentane-based modulators of STING (stimulator of interferon genes) External link
Filling date: 13 Sep 2025 Issue date: 6 Apr 2021
Grant
Utility: Stability-modulating linkers for use with antibody drug conjugates External link
Filling date: 13 Sep 2025 Issue date: 6 Apr 2021
Grant
Utility: Pyrrolo[2,3-d]pyrimidine derivatives External link
Filling date: 13 Sep 2025 Issue date: 6 Apr 2021
Grant
Utility: BTLA fusion protein agonists and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 30 Mar 2021
Application
Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF External link
Filling date: 13 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: BCKDK INHIBITORS External link
Filling date: 13 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: Modulators of STING (Stimulator of Interferon Genes) External link
Filling date: 13 Sep 2025 Issue date: 25 Mar 2021
Grant
Utility: Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same External link
Filling date: 13 Sep 2025 Issue date: 23 Mar 2021
Application
Utility: Methods and Combination Therapy to Treat Cancer External link
Filling date: 13 Sep 2025 Issue date: 18 Mar 2021
Grant
Utility: PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol External link
Filling date: 13 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Media and fermentation methods for producing polysaccharides in bacterial cell culture External link
Filling date: 13 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body External link
Filling date: 13 Sep 2025 Issue date: 16 Mar 2021
Application
Utility: PD-L1 ANTAGONIST COMBINATION TREATMENTS External link
Filling date: 13 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: Boron Containing PDE4 Inhibitors External link
Filling date: 13 Sep 2025 Issue date: 11 Mar 2021
Grant
Utility: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: Engineered polypeptide conjugates and methods for making thereof using transglutaminase External link
Filling date: 13 Sep 2025 Issue date: 9 Mar 2021
Application
Utility: BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE External link
Filling date: 13 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 4 Mar 2021
Grant
Utility: GLP-1 receptor agonists and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 2 Mar 2021
Application
Utility: THERAPEUTIC ANTIBODIES AND THEIR USES External link
Filling date: 13 Sep 2025 Issue date: 25 Feb 2021
Grant
Utility: Anti-CXCR4 antibodies and antibody-drug conjugates External link
Filling date: 13 Sep 2025 Issue date: 23 Feb 2021
Application
Utility: GLP-1 RECEPTOR AGONISTS AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS External link
Filling date: 13 Sep 2025 Issue date: 18 Feb 2021
Grant
Utility: Streptococcus pneumoniae capsular polysaccharides and conjugates thereof External link
Filling date: 13 Sep 2025 Issue date: 16 Feb 2021
Application
Utility: SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2- -METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: HUMANIZED ANTIBODIES External link
Filling date: 13 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: LFA3 VARIANTS AND COMPOSITIONS AND USES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 4 Feb 2021
Grant
Utility: Recombinant ROBO2 proteins, compositions, methods and uses thereof External link
Filling date: 13 Sep 2025 Issue date: 2 Feb 2021
Grant
Utility: Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme External link
Filling date: 13 Sep 2025 Issue date: 2 Feb 2021
Application
Utility: RSV F Protein Mutants External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: BCKDK INHIBITORS External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: PIPERAZINE AZASPIRO DERIVAVES External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY IN COMBINATION WITH 4-1BB AGONIST External link
Filling date: 13 Sep 2025 Issue date: 28 Jan 2021
Grant
Utility: Neisseria meningitidis compositions and methods thereof External link
Filling date: 13 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Combination of a PD-1 antagonist and a 4-1BB agonist for treating cancer External link
Filling date: 13 Sep 2025 Issue date: 26 Jan 2021

Showing 150 to 200 of 451 patents.